E, J., A, Y., RH, P., T, B., & A, F. (2026). Comprehensive pharmacokinetic/pharmacodynamic analysis of commercially available premixed daptomycin preparations against Staphylococcus aureus and Enterococcus spp. bloodstream infections using Monte Carlo simulation in adult patients. JAC-antimicrobial resistance, 8(1), dlaf253. https://doi.org/10.1093/jacamr/dlaf253
Chicago Style (17th ed.) CitationE, Jaime, Yassin A, Patel RH, Bhowmick T, and Farkas A. "Comprehensive Pharmacokinetic/pharmacodynamic Analysis of Commercially Available Premixed Daptomycin Preparations Against Staphylococcus Aureus and Enterococcus Spp. Bloodstream Infections Using Monte Carlo Simulation in Adult Patients." JAC-antimicrobial Resistance 8, no. 1 (2026): dlaf253. https://doi.org/10.1093/jacamr/dlaf253.
MLA (9th ed.) CitationE, Jaime, et al. "Comprehensive Pharmacokinetic/pharmacodynamic Analysis of Commercially Available Premixed Daptomycin Preparations Against Staphylococcus Aureus and Enterococcus Spp. Bloodstream Infections Using Monte Carlo Simulation in Adult Patients." JAC-antimicrobial Resistance, vol. 8, no. 1, 2026, p. dlaf253, https://doi.org/10.1093/jacamr/dlaf253.